683 related articles for article (PubMed ID: 19258384)
1. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
[TBL] [Abstract][Full Text] [Related]
2. Biocompatible peritoneal dialysis solution preserves residual renal function.
Kim S; Oh KH; Oh J; Kim SJ; Chung W; Song YR; Na KY; Oh YK; Ahn C; Kim SG; Tan KC
Am J Nephrol; 2012; 36(4):305-16. PubMed ID: 23007025
[TBL] [Abstract][Full Text] [Related]
3. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
4. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
[TBL] [Abstract][Full Text] [Related]
5. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
[TBL] [Abstract][Full Text] [Related]
6. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function.
Wang AY; Woo J; Wang M; Sea MM; Sanderson JE; Lui SF; Li PK
Nephrol Dial Transplant; 2005 Feb; 20(2):396-403. PubMed ID: 15187196
[TBL] [Abstract][Full Text] [Related]
7. Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet Study).
Kim SG; Kim S; Hwang YH; Kim K; Oh JE; Chung W; Oh KH; Kim HJ; Ahn C;
Perit Dial Int; 2008 Jun; 28 Suppl 3():S117-22. PubMed ID: 18552239
[TBL] [Abstract][Full Text] [Related]
8. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
[TBL] [Abstract][Full Text] [Related]
9. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
Fusshoeller A; Plail M; Grabensee B; Plum J
Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
[TBL] [Abstract][Full Text] [Related]
11. The effect of peritoneal dialysis method on residual renal function in children.
Roszkowska-Blaim M; Skrzypczyk P; Jander A; Tkaczyk M; Bałasz-Chmielewska I; Zurowska A; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2012; 28():112-9. PubMed ID: 23311226
[TBL] [Abstract][Full Text] [Related]
12. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
13. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
[TBL] [Abstract][Full Text] [Related]
14. Independent effects of residual renal function and dialysis adequacy on nutritional status and patient outcome in continuous ambulatory peritoneal dialysis.
Szeto CC; Lai KN; Wong TY; Law MC; Leung CB; Yu AW; Li PK
Am J Kidney Dis; 1999 Dec; 34(6):1056-64. PubMed ID: 10585315
[TBL] [Abstract][Full Text] [Related]
15. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study.
Haag-Weber M; Krämer R; Haake R; Islam MS; Prischl F; Haug U; Nabut JL; Deppisch R;
Nephrol Dial Transplant; 2010 Jul; 25(7):2288-96. PubMed ID: 20197284
[TBL] [Abstract][Full Text] [Related]
16. Incremental dialysis with automated peritoneal dialysis.
Neri L; Viglino G; Cappelletti A; Gandolfo C; Barbieri S
Adv Perit Dial; 2003; 19():93-6. PubMed ID: 14763041
[TBL] [Abstract][Full Text] [Related]
17. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
[TBL] [Abstract][Full Text] [Related]
18. Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients.
Oh KH; Moon JY; Oh J; Kim SG; Hwang YH; Kim S; Lee JS; Ahn C
Nephrol Dial Transplant; 2008 Jul; 23(7):2356-64. PubMed ID: 18178604
[TBL] [Abstract][Full Text] [Related]
19. Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study.
Dittrich E; Puttinger H; Schillinger M; Lang I; Stefenelli T; Hörl WH; Vychytil A
Nephrol Dial Transplant; 2006 May; 21(5):1334-9. PubMed ID: 16046499
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
